Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Officer of Protagonist Therapeutics, Inc. (NASDAQ:PTGX), a $2.2 billion market cap biotech company, recently reported the sale of 3,640 shares of common stock on January 16, 2025. The transactions ...